P3 Health Partners Inc.
PIII · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $345 | $356 | $373 | $371 |
| % Growth | -3% | -4.7% | 0.7% | – |
| Cost of Goods Sold | $370 | $0 | $379 | $0 |
| Gross Profit | -$25 | $356 | -$6 | $371 |
| % Margin | -7.1% | 100% | -1.5% | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $22 | $23 | $25 | $31 |
| SG&A Expenses | $22 | $23 | $25 | $32 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$3 | $366 | $7 | $477 |
| Operating Expenses | $20 | $390 | $32 | $509 |
| Operating Income | -$44 | -$34 | -$38 | -$139 |
| % Margin | -12.8% | -9.6% | -10.2% | -37.4% |
| Other Income/Exp. Net | -$25 | -$8 | -$5 | $14 |
| Pre-Tax Income | -$69 | -$42 | -$43 | -$124 |
| Tax Expense | $0 | $2 | $1 | $5 |
| Net Income | -$32 | -$20 | -$20 | -$59 |
| % Margin | -9.1% | -5.7% | -5.5% | -15.8% |
| EPS | -9.67 | -6.23 | -6.28 | -18.02 |
| % Growth | -55.2% | 0.8% | 65.1% | – |
| EPS Diluted | -9.67 | -6.23 | -6.28 | -20.82 |
| Weighted Avg Shares Out | 3 | 3 | 3 | 3 |
| Weighted Avg Shares Out Dil | 3 | 3 | 3 | 3 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $21 | $10 | $9 | $7 |
| Depreciation & Amortization | $21 | $21 | $21 | $21 |
| EBITDA | -$28 | -$10 | -$13 | -$96 |
| % Margin | -8.1% | -2.9% | -3.6% | -26% |